A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression

被引:121
|
作者
Burk, O [1 ]
Arnold, KA [1 ]
Geick, A [1 ]
Tegude, H [1 ]
Eichelbaum, M [1 ]
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
关键词
gene regulation; nuclear receptor; P-glycoprotein;
D O I
10.1515/BC.2005.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MDR1/P-glycoprotein is an efflux transporter determining the absorption and presystemic elimination of many xenobiotics in the gut. Thus, interindividual differences in MDR1 expression may affect the efficacy of drug treatment. The expression of MDR1 is partially controlled by the pregnane X receptor (PXR), which mediates induction by many xenobiotics. Since it has been described that the nuclear receptors PXR and constitutive androstane receptor (CAR) can bind to the same binding sites, we investigated the role of CAR in the regulation of MDR1 gene expression. We demonstrate here by gel shift and transfection experiments that CAR binds to distinct nuclear receptor response elements in the -7.8 kbp enhancer of MDR1 and transactivates MDR1 expression through DR4 motifs to which the receptor binds as. a heterodimer with RXR or as a monomer, respectively. Expression of the endogenous MDR1 gene is elevated in cells stably expressing CAR, thus arguing for the functional relevance of CAR-dependent activation of MDR1. The physiological relevance of the regulation of MDR1 by CAR is further suggested by correlation of the expression of CAR and MDR1 in the human small intestine. In summary, our data suggest that CAR plays a role in the regulation of intestinal MDR1 expression.
引用
收藏
页码:503 / 513
页数:11
相关论文
共 50 条
  • [41] MDR1 expression in ocular melanoma
    Dunne, B
    McNamara, M
    Kennedy, SM
    LABORATORY INVESTIGATION, 1996, 74 (01) : 581 - 581
  • [42] Zosuquidar, an MDR1 inhibitor, activates human pxr to induce CYP3A4 and MDR1 gene expression
    Pondugula, Satyanarayana R.
    Abbott, Kodye L.
    Flannery, Patrick C.
    Tiwari, Amit K.
    DRUG METABOLISM REVIEWS, 2016, 48 : 81 - 81
  • [43] Expression and role of multidrug resistant protein 1 (mdr1) in rat prostate
    Tanaka, M
    Watanabe, M
    Nakaya, S
    Kumai, T
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 257P - 257P
  • [44] Stereoisomerization of human constitutive androstane receptor agonist CITCO
    Diethelm-Varela, Benjamin
    Kumar, Anmol
    Lynch, Caitlin
    Imler, Gregory H.
    Deschamps, Jeffrey R.
    Li, Yue
    Xia, Menghang
    MacKerell, Alexander D., Jr.
    Xue, Fengtian
    TETRAHEDRON, 2021, 79
  • [45] Alternatively spliced isoforms of the human constitutive androstane receptor
    Auerbach, SS
    Ramsden, R
    Stoner, MA
    Verlinde, C
    Hassett, C
    Omiecinski, CJ
    NUCLEIC ACIDS RESEARCH, 2003, 31 (12) : 3194 - 3207
  • [46] Differential regulation of constitutive androstane receptor expression by hepatocyte nuclear factor4α lsoforms
    Pascussi, Jean Marc
    Robert, Agnes
    Moreau, Amehe
    Ramos, Jeanne
    Bioulac-Sage, Paulette
    Navarro, Francis
    Blanc, Pierre
    Assenat, Eric
    Maurel, Patrick
    Vilarem, Marie Jose
    HEPATOLOGY, 2007, 45 (05) : 1146 - 1153
  • [47] Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells
    Haslam, I. S.
    Jones, K.
    Coleman, T.
    Simmons, N. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (01) : 246 - 255
  • [48] Characterization of the human MDR1 gene
    Bodor, M
    Kelly, EJ
    Ho, RJ
    AAPS JOURNAL, 2005, 7 (01): : E1 - E5
  • [49] Thyroid hormone receptor mediates human MDR1 gene expression -: Identification of the response region essential for gene expression
    Kurose, Kouichi
    Saeki, Mayumi
    Tohkin, Masahiro
    Hasegawa, Ryuichi
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2008, 474 (01) : 82 - 90
  • [50] EXPRESSION OF MDR1 GENE IN HUMAN BREAST PRIMARY TUMORS AND METASTASES
    HENNEQUIN, E
    DELVINCOURT, C
    POURNY, C
    JARDILLIER, JC
    BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (03) : 267 - 274